International Registry for Patients With Castleman Disease

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT02817997
Status
Recruiting
Apply to this trial

Conditions

  • Angiofollicular Lymph Hyperplasia
  • Angiofollicular Lymph Node Hyperplasia
  • Angiofollicular Lymphoid Hyperplasia
  • Castleman Disease
  • Castleman's Disease
  • GLNH
  • Giant Lymph Node Hyperplasia
  • Hyperplasia, Giant Lymph Node
  • Lymph Node Hyperplasia, Giant

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.

Key Dates

Start date
Oct 31, 2016
Status verified
Feb 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Common Symptoms [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of PennsylvaniaPhiladelphiaPennsylvania19104
Joshua Brandstadter, MD, PhD, MSc
[email protected]
267-847-8220
Bridget Austin, MSc
[email protected]
267-586-9977
Joshua C Brandstadter, MD, PhD, MSc (PRINCIPAL_INVESTIGATOR)

Find similar trials in Philadelphia, PA

By research site
University of Pennsylvania· Philadelphia, PA

Related Studies